Skip to main content

CannabisNewsBreaks – No Borders, Inc. (NBDR) Commences Receiving, Shipping 15 Minute COVID-19 Serological Tests in the US

No Borders (OTC: NBDR) on Friday announced that it has, in the past week, received its initial shipment of COVID-19 serological tests into its Phoenix, Arizona operations center, with the first shipment sent out last Wednesday to a New Jersey municipality. According to the update, the Company has been able to, through its medical supply chains, import a 15-minute COVID-19 test for distribution. Using a serology test, patients are able to see if their body has developed antibodies potentially created through infection with the COVID-19 virus. Manufacturers of the SARS-CoV-2 IgM/IgG Antibody Rapid Test Kit in China have applied for the Emergency use Authorization (“EUA”) registration with the Food and Drug Administration (“FDA”), allowing them to be sold in the United States. While manufacturers have applied for their respective EUA’s, the FDA, as of yet, has not approved these tests. Negative results do not rule out SARS-CoV-2 infection, and positive results may be due to a past or present infection of SARS-CoV2 or similar coronavirus strain such as, for example, HKU1 or NL63.

To view the full press release, visit http://cnw.fm/jM5po

About No Borders, Inc.

No Borders, Inc. (OTC: NBDR) is a multifaceted corporation specializing in the acquisition, creation, and scaling of commercial and consumer products by utilizing cutting-edge technologies to reduce costs while increasing revenues and shareholder value through technological superiority and Intellectual Property ownership across its portfolio of assets. The Company’s portfolio of brands includes:

  • No Borders Naturals Inc., a purveyor of health and wellness products for active consumers and their pets (NoBordersNaturals.com).
  • No Borders Labs Inc., which provides leading-edge tech tools to NBDR internal companies while also offering consulting, architecture and software development services to external businesses looking to update their technology infrastructure for greater efficiency, security, and transparency (NoBordersLabs.com).
  • CBDLabChain.com a powerful, Patent Pending tool to demonstrate in an unbiased and unchangeable way a clear sense of security to consumers of CBD products by recording Certificate of Authority (COA) on a blockchain technology platform.
  • No Borders Dental Resources Inc., a provider of equipment and supplies to medical and dental professionals across the U.S. through the trade name MediDent Supplies (MediDentSupplies.com).

No Borders is headquartered in Arizona with resources in the U.S., South America, Asia, and Europe. For more information, visit the Company’s website at www.NBDR.co.

NOTE TO INVESTORS: The latest news and updates relating to NBDR are available in the company’s newsroom at http://cnw.fm/NBDR

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “CANNABIS” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CannabisNewsWire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have a questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.CannabisNewsWire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.